Clinical Trial

A First-in-Human Study of FID-022 in Solid Tumor Patients

Recruiting
View on ClinicalTrials.gov →
Summary
This observational study aims to (1) validate a multimodal artificial intelligence (AI) model for early detection of cancer-associated cachexia in pancreatic cancer patients and (2) assess the feasibility and acceptability of diet and exercise interventions for cachexia management. The study will use retrospective data from the Florida Pancreas Collaborative and prospective data from newly diagnosed patients at Moffitt Cancer Center.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-18.
Trial Details
NCT Number NCT07249775
Lead Sponsor H. Lee Moffitt Cancer Center and Research Institute
Collaborators: Florida Cancer Innovation Fund
Conditions Pancreatic Cancer, Cancer Cachexia
Enrollment 120 participants
Start Date 2025-10-08
Primary Completion 2026-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-01-28